Collegium Pharmaceutical (COLL) Assets (2014 - 2026)

Collegium Pharmaceutical's Assets history runs 13 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• On a quarterly basis, Assets rose 1.26% year-over-year to $1.7 billion in Q1 2026; TTM through Mar 2026 was $1.7 billion, a 1.26% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, changed 0.41% from the prior year.
• Assets was little changed at $1.7 billion in Q1 2026 per COLL's latest filing, from $1.7 billion in the prior quarter.
• Across five years, Assets topped out at $1.7 billion in Q4 2024 and bottomed at $1.1 billion in Q2 2024.
• The 5-year median for Assets is $1.2 billion (2022), against an average of $1.4 billion.
• Across the five-year window, Assets soared 92.88% in 2022 and retreated 13.22% in 2024, its largest moves.
• Year by year, Assets stood at $1.2 billion in 2022, then decreased by 2.63% to $1.1 billion in 2023, then surged by 45.51% to $1.7 billion in 2024, then retreated by 0.41% to $1.7 billion in 2025, then slipped by 0.29% to $1.7 billion in 2026.
• Per Business Quant, the three latest COLL Assets figures stand at $1.7 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.6 billion (Q3 2025).